Literature DB >> 15308280

Antibiotics for gram-positive bacterial infections: vancomycin, quinupristin-dalfopristin, linezolid, and daptomycin.

Tammy S Lundstrom1, Jack D Sobel.   

Abstract

An overview of the mechanism of action, dosing, clinical indications, and toxicities of the glycopeptide vancomycin is provided. Emerging gram-positive bacterial resistance to antimicrobials and its mechanisms are reviewed. Strategies to control emergence of resistance are proposed. Newer antimicrobial agents with activity against vancomycin-resistant organisms are now available and play a critical role in the treatment of life-threatening infections.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15308280     DOI： 10.1016/j.idc.2004.04.014

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN： 0891-5520            Impact factor:   5.982


  9 in total

1.  Vancomycin bonded to bone grafts prevents bacterial colonization.

Authors:  Constantinos Ketonis; Stephanie Barr; Christopher S Adams; Irving M Shapiro; Javad Parvizi; Noreen J Hickok
Journal:  Antimicrob Agents Chemother       Date:  2010-11-22       Impact factor: 5.191

2.  Evaluation of the stability of vancomycin solutions at concentrations used in clinical services.

Authors:  Morgane Masse; Stéphanie Genay; Anthony Martin Mena; Natacha Carta; Damien Lannoy; Christine Barthélémy; Bertrand Décaudin; Pascal Odou
Journal:  Eur J Hosp Pharm       Date:  2020-02-05

3.  External Evaluation of Population Pharmacokinetic Models of Vancomycin in Neonates: The transferability of published models to different clinical settings.

Authors:  Wei Zhao; Florentia Kaguelidou; Valérie Biran; Daolun Zhang; Karel Allegaert; Edmund V Capparelli; Nick Holford; Toshimi Kimura; Yoke-Lin Lo; José-Esteban Peris; Alison Thomson; John N van den Anker; May Fakhoury; Evelyne Jacqz-Aigrain
Journal:  Br J Clin Pharmacol       Date:  2013-04       Impact factor: 4.335

4.  Pulmonary versus systemic delivery of antibiotics: comparison of vancomycin dispositions in the isolated rat lung.

Authors:  María José de Jesús Valle; Francisco González López; Alfonso Domínguez-Gil Hurlé; Amparo Sánchez Navarro
Journal:  Antimicrob Agents Chemother       Date:  2007-08-06       Impact factor: 5.191

5.  Novel Bone-Targeting Agent for Enhanced Delivery of Vancomycin to Bone.

Authors:  Zaineb A F Albayati; Manjula Sunkara; Suzannah M Schmidt-Malan; Melissa J Karau; Andrew J Morris; James M Steckelberg; Robin Patel; Philip J Breen; Mark S Smeltzer; K Grant Taylor; Kevyn E Merten; William M Pierce; Peter A Crooks
Journal:  Antimicrob Agents Chemother       Date:  2015-12-14       Impact factor: 5.191

6.  Hyaluronic Acid-Based Hydrogel Coating Does Not Affect Bone Apposition at the Implant Surface in a Rabbit Model.

Authors:  W Boot; D Gawlitta; P G J Nikkels; B Pouran; M H P van Rijen; W J A Dhert; H Ch Vogely
Journal:  Clin Orthop Relat Res       Date:  2017-03-16       Impact factor: 4.176

7.  Identification of genes associated with tongue cancer in patients with a history of tobacco and/or alcohol use.

Authors:  Yin Zhao; Dongna Fu; Chengbi Xu; Jingpu Yang; Zonggui Wang
Journal:  Oncol Lett       Date:  2016-12-14       Impact factor: 2.967

8.  Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005).

Authors:  Helio S Sader; Amy A Watters; Thomas R Fritsche; Ronald N Jones
Journal:  BMC Infect Dis       Date:  2007-04-18       Impact factor: 3.090

9.  Development and validation of an HPLC method for the determination of vancomycin in human plasma and its comparison with an immunoassay (PETINIA).

Authors:  Muhammad Usman; Georg Hempel
Journal:  Springerplus       Date:  2016-02-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.